DiaMedica Therapeutics
Price & Volume
Stats
See more52W Range | $3.19-$7.48 |
Market Cap | $360.7M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.71 |
News
See moreYahoo Finance • last month
DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Reports Q2 2025 Earnings: Narrower Loss and Promising Clinical Updates Drive Stock Surge
Yahoo Finance • 2 months ago
DiaMedica therapeutics (DMAC): Trill AB buys $5.4m in shares
Yahoo Finance • 2 months ago
DiaMedica therapeutics (DMAC) shareholder TomEnterprise Private AB buys $10M in stock
Yahoo Finance • 2 months ago
DiaMedica Therapeutics raises $30 million in private placement
About
CEO | Mr. Dietrich John Pauls MBA |
Address | 301 Carlson Parkway, Minneapolis, MN, United States, 55305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 27 |
